Evidence map›Paper›PMID 23580574›Full record

ReviewCancer research2013

Understanding phenotypic variation in rodent models with germline Apc mutations.

Maged Zeineldin, Kristi L Neufeld

Abstract readReview
In one paragraph

Review in Cancer research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Toward a CRISPR-based mouse model ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genetically Engineered Pigs to Study Cancer.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Suppression of intestinal tumorigenesis inJournal of cell science · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Three novel mutations of APC gene in Chinese patients with familial adenomatous polyposis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maged ZeineldinDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, USA.
Kristi L Neufeld

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
UNDERSTANDING THE ROLE OF SMALL RNAS IN ARABIDOPSIS POLLEN DEVELOPMENTP20RR016475 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ACKLEY, BRIAN DOUGLAS · 2001 to 2011
$38.1M
Nuclear functions of the tumor suppressor protein APCR01CA109220 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI NEUFELD, KRISTI L · 2004 to 2008
$1.2M
NCI NIH HHS R01 CA109220NCRR NIH HHS P20 RR016475NIGMS NIH HHS P20 GM103418
6 · The paper itself

Abstract

Adenomatous polyposis coli (APC) is best known for its crucial role in colorectal cancer suppression. Rodent models with various Apc mutations have enabled experimental validation of different Apc functions in tumors and normal tissues. Since the development of the first mouse model with a germline Apc mutation in the early 1990s, 20 other Apc mouse and rat models have been generated. This article compares and contrasts currently available Apc rodent models with particular emphasis on providing potential explanations for their reported variation in three areas: (i) intestinal polyp multiplicity, (ii) intestinal polyp distribution, and (iii) extraintestinal phenotypes.

Indexed as

Germ-Line MutationPhenotypeAdenomatous Polyposis ColiAdenomatous Polyposis Coli ProteinAnimalsCell Transformation, NeoplasticDisease Models, AnimalGenetic Association StudiesHumansIntestinal PolypsMiceRatsRodentiaAdenomatous Polyposis Coli Protein

Identifiers

PMID23580574
PMCPMC3630257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.